Tuberculosis lymphadenopathy: A rare etiology of the superior vena cava syndrome

J Med Vasc. 2021 Feb;46(1):9-12. doi: 10.1016/j.jdmv.2020.11.001. Epub 2020 Dec 2.

Abstract

Superior vena cava syndrome is the clinical expression of the obstruction of the superior vena cava reducing the blood flow. Malignant etiologies are the most common. Its management is multidisciplinary and despite the progress of endovascular procedures, conventional surgery retains its place in certain indications. Mediastinal fibrosis secondary to tuberculosis lymphadenopathy may be associated with superior vena cava syndrome. In the presence of symptomatic SVCS associated with extensive mediastinal fibrosis compressing the superior vena cava with sub occlusive thrombosis, conventional surgery remains a treatment option, with cavo-venous derivation by prosthetic bypass.

Keywords: Cavo-venous bypass; Mediastinal fibrosis; Superior vena cava syndrome; Tuberculosis.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Antitubercular Agents / therapeutic use
  • Blood Vessel Prosthesis Implantation
  • Female
  • Humans
  • Mediastinitis / diagnostic imaging
  • Mediastinitis / drug therapy
  • Mediastinitis / etiology*
  • Sclerosis / diagnostic imaging
  • Sclerosis / drug therapy
  • Sclerosis / etiology*
  • Superior Vena Cava Syndrome / diagnostic imaging
  • Superior Vena Cava Syndrome / etiology*
  • Superior Vena Cava Syndrome / surgery
  • Treatment Outcome
  • Tuberculosis, Lymph Node / complications*
  • Tuberculosis, Lymph Node / diagnosis
  • Tuberculosis, Lymph Node / drug therapy

Substances

  • Adrenal Cortex Hormones
  • Antitubercular Agents

Supplementary concepts

  • Mediastinal Fibrosis